Bettina M. Cockroft's most recent trade in Annexon Inc was a trade of 65,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annexon Inc | Dr. Bettina M. Cockroft, M.D. | Director | 11 Jun 2026 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
| Cns Pharma Inc | Dr. Bettina M. Cockroft, M.D. | Director | 17 Nov 2025 | 1,517 | 1,517 | - | - | Option to purchase common stock | ||
| Annexon Inc | Dr. Bettina M. Cockroft, M.D. | Director | 05 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| Annexon Inc | Ms. Bettina M. Cockroft | Director | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | ||
| Cns Pharma Inc | Ms. Bettina M. Cockroft | Director | 08 Apr 2024 | 17,500 | 35,574 | - | - | Option to purchase common stock | ||
| Cns Pharma Inc | Ms. Bettina M. Cockroft | Director | 08 Apr 2024 | 17,500 | 53,074 | - | - | Restricted Stock Units | ||
| Annexon Inc | Ms. Bettina M. Cockroft | Director | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | ||
| Cns Pharma Inc | Ms. Bettina M. Cockroft | Director | 05 May 2023 | 2,099 | 2,099 | - | - | Option to purchase common stock | ||
| Annexon Inc | Ms. Bettina M. Cockroft | Director | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | ||
| Annexon Inc | Ms. Bettina M. Cockroft | Director | 19 Jan 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |